Elevated VEGF concentrations in ascites and serum predict adverse prognosis in ovarian cancer

Author： Liang Bin   Guo Zhengdong   Li Yunhui   Liu Chuan  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.73, Iss.4, 2013-06, pp. : 309-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 172-174

Karger

Access to resources Recommend Favorite

Platelet-Derived Growth Factor Receptor Beta Serum Concentrations during First-Line Therapy in Ovarian Cancer

By  

Oncology, Vol. 85, Iss. 2, 2013-07 ,pp. : 69-77

Karger

Access to resources Recommend Favorite

A Comparison of Fentanyl and Flurbiprofen Axetil on Serum VEGF‐C, TNF‐α, and IL‐1ß Concentrations in Women Undergoing Surgery for Breast Cancer

By  

PAIN PRACTICE, Vol. 15, Iss. 6, 2015-07 ,pp. : 530-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Signatures of Ovarian Cancer: From Detection to Prognosis

By Walsh Christine S.   Karlan Beth Y.  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 13-22

Adis International

Access to resources Recommend Favorite

Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer

By  

Oncology, Vol. 90, Iss. 2, 2016-0 ,pp. : 59-68

Karger

Access to resources Recommend Favorite